The Role of Endothelial Glycocalyx in Kidney Transplantation

Launched by CHARLES UNIVERSITY, CZECH REPUBLIC · Dec 13, 2022

Keywords

ClinConnect Summary

This clinical trial is studying a part of the blood vessel lining called the endothelial glycocalyx (EG) and its role in kidney transplantation. Researchers want to learn more about how EG breaks down before and after a kidney transplant by checking blood and urine samples from both the kidney donors and the recipients. They will also use a special imaging technique to visualize the EG directly. The goal is to better understand how EG affects kidney transplants and why it is important.

To participate in this study, you need to be someone who is undergoing a kidney transplant. The trial is open to all genders, and the only requirement is that you must agree to participate by signing an informed consent form. If you join the study, you can expect to have your blood and urine tested, and you may undergo some imaging procedures to help researchers gather important information. This study is currently recruiting participants, so if you or someone you know is considering a kidney transplant, this could be an opportunity to contribute to important research.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients undergoing kidney transplantation
• Exclusion Criteria:
• • Patients who don't sign the informed consent